Bioelectricity Startup Raises $95M to Build the First Drug-Free Hypertension Device
Bioelectronics startup BackBeat Medical closed a $95M Series C to scale its implantable cardiac pacemaker-based system that reduces blood pressure without drugs — through precisely timed electrical pulses.